中西医结合治疗肝硬化腹水80例临床观察

目的：观察中西医结合治疗肝硬化腹水的临床效果。方法：运用随机抽样的方法选取本院2010年1月-2014年4月收治的160例肝硬化腹水患者,依据随机数字表法将这些患者分为研究组和对照组,每组各80例。对照组给予患者单纯西医治疗,研究组给予患者中西医结合治疗。结果：研究组患者治疗的总有效率98.75%（79/80）显著高于对照组76.25%（61/80）,差异有统计学意义（P〈0.05）;ALT、AST、TBIL水平均显著低于对照组,差异有统计学意义（P〈0.05）;Alb水平显著高于对照组,差异有统计学意义（P〈0.05）;门静脉内径显著短于对照组,差异有统计学意义（P〈0.05）;半年、半年至1年、1年以上复发率5.00%（4/80）、10.00%（8/80）、12.50%（10/80）均显著低于对照组16.25%（13/80）、20.00%（16/80）、25.00%（20/80）,差异有统计学意义（P〈0.05）。结论：中西医结合治疗肝硬化腹水较单纯西医治疗更能有效提高对患者治疗的总有效率,改善患者肝功能,降低患者的远期复发率。

Clinical Observation of Integrative Medicine in the Treatment of 80 Cases of Liver Cirrhosis

Objective： To observe the clinical effects of Integrative Medicine in the treatment of liver cirrhosis. Method：160 cases of liver cirrhosis patients who were treated in our hospital from January 2010 to April 2014 were selected by a random sampling method, these patients were divided into study group and control group according to a random number table,80 cases in each group. The control group of patients were given western medicine, while the study group of patients were integrative medicine. Result： The total efficiency of the study group was 98.75%（79/80） significantly higher than the control group 76.25%（61/80）,the difference was statistically significant（P〈0.05）; the ALT, AST and TBIL levels were significantly lower than the control group, the difference was statistically significant（P〈0.05）; the Alb level was significantly higher than the control group,the difference was statistically significant（P〈0.05）; the portal vein diameter was significantly shorter control group than the control group,the difference was statistically significant（P〈0.05）; the six months, six months to a year, more than one year recurrence rate were respectively 5.00%（4/80）,10.00%（8/80）,12.50%（10/80） significantly lower than the control group 16.25%（13/80）,20.00%（16/80）,25.00%（20/80）,the difference was statistically significant（P〈0.05）. Conclusion： Integrative Medicine is more effective increasing the total efficiency,improving liver function, reducing the long-term relapse rate of patients than simple western medicine in the treatment of liver cirrhosis.